Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin
Author(s) -
Gloria S. Tannenbaum
Publication year - 1992
Publication title -
endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.674
H-Index - 257
eISSN - 1945-7170
pISSN - 0013-7227
DOI - 10.1210/en.130.6.3395
Subject(s) - tamoxifen , endocrinology , medicine , somatostatin , estrogen , pulsatile flow , estrogen receptor , receptor , biology , breast cancer , cancer
Tamoxifen, a partial competitive anatgonist to the estrogen receptor, is a potent ainhibitor of the proliferation of experimental mammary carcinoma in the rat and is widely used clinically in the treatment of breast cancer.[...
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom